Skip to main content
Top
Published in: Neurological Sciences 1/2012

01-05-2012 | SYMPOSIUM: PERIPHERAL NEUROMODULATION IN CHRONIC MIGRAINE

Peripheral neuromodulation in chronic migraine

Authors: F. Perini, A. De Boni

Published in: Neurological Sciences | Special Issue 1/2012

Login to get access

Abstract

Patients with chronic migraines are often refractory to medical treatment. Therefore, they might need other strategies to modulate their pain, according to their level of disability. Neuromodulation can be achieved with several tools: meditation, biofeedback, physical therapy, drugs and electric neurostimulation (ENS). ENS can be applied to the central nervous system (brain and spinal cord), either invasively (cortical or deep brain) or non-invasively [cranial electrotherapy stimulation, transcranial direct current stimulation and transcranial magnetic stimulation]. Among chronic primary headaches, cluster headaches are most often treated either through deep brain stimulation or occipital nerve stimulation because there is a high level of disability related to this condition. ENS, employed through several modalities such as transcutaneous electrical nerve stimulation, interferential currents and pulsed radiofrequency, has been applied to the peripheral nervous system at several sites. We briefly review the indications for the use of peripheral ENS at the site of the occipital nerves for the treatment of chronic migraine.
Literature
1.
go back to reference D’Amico D, Grazzi L, Usai S, Raggi A, Leonardi M, Bussone G (2011) Disability in chronic daily headache: state of the art and future directions. Neurol Sci 32 Suppl 1:S71–6 D’Amico D, Grazzi L, Usai S, Raggi A, Leonardi M, Bussone G (2011) Disability in chronic daily headache: state of the art and future directions. Neurol Sci 32 Suppl 1:S71–6
2.
go back to reference Lipton RB (2011) Chronic migraine, classification, differential diagnosis, and epidemiology. Headache 51(Suppl 2):77–83PubMedCrossRef Lipton RB (2011) Chronic migraine, classification, differential diagnosis, and epidemiology. Headache 51(Suppl 2):77–83PubMedCrossRef
3.
go back to reference Manzoni GC, Bonavita V, Bussone G, Cortelli P, Narbone MC, Cevoli S, D’Amico D, De Simone R, Torelli P, On behalf of ANIRCEF (Associazione Neurologica Italiana Ricerca Cefalee) (2011) Chronic migraine classification: current knowledge and future perspectives. J Headache Pain 12:585–592PubMedCrossRef Manzoni GC, Bonavita V, Bussone G, Cortelli P, Narbone MC, Cevoli S, D’Amico D, De Simone R, Torelli P, On behalf of ANIRCEF (Associazione Neurologica Italiana Ricerca Cefalee) (2011) Chronic migraine classification: current knowledge and future perspectives. J Headache Pain 12:585–592PubMedCrossRef
4.
go back to reference Goadsby PJ, Schoenen J, Ferrari M et al (2006) Towards a definition of refractory headache for use in clinical practice and trials. Cephalalgia 26:1168–1170PubMedCrossRef Goadsby PJ, Schoenen J, Ferrari M et al (2006) Towards a definition of refractory headache for use in clinical practice and trials. Cephalalgia 26:1168–1170PubMedCrossRef
5.
go back to reference Schulman EA, Lake AE, Goadsby PJ et al (2008) Defining refractory migraine and refractory chronic migraine: proposed criteria from the refractory headache special interest section of the American Headache Society. Headache. 48:778–782PubMedCrossRef Schulman EA, Lake AE, Goadsby PJ et al (2008) Defining refractory migraine and refractory chronic migraine: proposed criteria from the refractory headache special interest section of the American Headache Society. Headache. 48:778–782PubMedCrossRef
6.
go back to reference Schulman EA, Peterlin BL, Lake AE, Lipton RB, Hanlon A, Siegel S, Levin M, Goadsby PJ, Markley HG (2009) Defining refractory migraine: results of the RHSIS Survey of American Headache Society members. Headache 49:509–518PubMedCrossRef Schulman EA, Peterlin BL, Lake AE, Lipton RB, Hanlon A, Siegel S, Levin M, Goadsby PJ, Markley HG (2009) Defining refractory migraine: results of the RHSIS Survey of American Headache Society members. Headache 49:509–518PubMedCrossRef
7.
go back to reference Irimia P, Palma JA, Fernandez-Torron R, Martinez-Vila E (2011) Refractory migraine in a headache clinic population. BMC Neurol 11:94 Irimia P, Palma JA, Fernandez-Torron R, Martinez-Vila E (2011) Refractory migraine in a headache clinic population. BMC Neurol 11:94
8.
go back to reference Silberstein SD, Dodick DW, Pearlman S (2010) Defining the pharmacologically intractable headache for clinical trials and clinical practice. Headache 50:1499–1506PubMedCrossRef Silberstein SD, Dodick DW, Pearlman S (2010) Defining the pharmacologically intractable headache for clinical trials and clinical practice. Headache 50:1499–1506PubMedCrossRef
9.
go back to reference Pattle RE, Weddell G (1948) Observations on electrical stimulation of pain fibres in an exposed human sensory nerve. J Neurophysiol 11(2):93–98PubMed Pattle RE, Weddell G (1948) Observations on electrical stimulation of pain fibres in an exposed human sensory nerve. J Neurophysiol 11(2):93–98PubMed
10.
go back to reference Jenkins B, Tepper SJ (2011) Neurostimulation for primary headache disorders, part 1: pathophysiology and anatomy, history of neuromodulation in headache treatment, and review of peripheral neuromodulation in primary headaches. Headache 51(8):1254–1266 ReviewPubMedCrossRef Jenkins B, Tepper SJ (2011) Neurostimulation for primary headache disorders, part 1: pathophysiology and anatomy, history of neuromodulation in headache treatment, and review of peripheral neuromodulation in primary headaches. Headache 51(8):1254–1266 ReviewPubMedCrossRef
11.
go back to reference Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ, ONSTIM Investigators (2011) Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia 31(3):271–285PubMedCrossRef Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ, ONSTIM Investigators (2011) Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia 31(3):271–285PubMedCrossRef
12.
go back to reference Popeney C, Alo K (2003) Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine. Headache 43:369–375PubMedCrossRef Popeney C, Alo K (2003) Peripheral neurostimulation for the treatment of chronic, disabling transformed migraine. Headache 43:369–375PubMedCrossRef
13.
go back to reference Schwedt TJ, Dodick DW, Hentz J, Trentman TL, Zimmerman RS (2007) Occipital nerve stimulation for chronic headache—long-term safety and efficacy. Cephalalgia 27:153–157 Schwedt TJ, Dodick DW, Hentz J, Trentman TL, Zimmerman RS (2007) Occipital nerve stimulation for chronic headache—long-term safety and efficacy. Cephalalgia 27:153–157
14.
go back to reference Trentman TL, Rosenfeld DM, Vargas BB, Schwedt TJ, Zimmerman RS, Dodick DW (2009) Greater occipital nerve stimulation via the Bion microstimulator: implantation technique and stimulation parameters. Clinical trial: NCT00205894. Pain Physician 12(3):621–628PubMed Trentman TL, Rosenfeld DM, Vargas BB, Schwedt TJ, Zimmerman RS, Dodick DW (2009) Greater occipital nerve stimulation via the Bion microstimulator: implantation technique and stimulation parameters. Clinical trial: NCT00205894. Pain Physician 12(3):621–628PubMed
15.
go back to reference Silberstein S, Dodick D, Saper J, Huh B et al (2011) The safety and efficacy of peripheral nerve stimulation of the occipital nerve for the management of chronic migraine. Poster presented at: 15th Congress of the International Headache Society, Berlin, 23–26 June 2011 Silberstein S, Dodick D, Saper J, Huh B et al (2011) The safety and efficacy of peripheral nerve stimulation of the occipital nerve for the management of chronic migraine. Poster presented at: 15th Congress of the International Headache Society, Berlin, 23–26 June 2011
16.
go back to reference D’Amico D, Leone M, Grazzi L, Bussone G (2008) When should “chronic migraine” patients be considered “refractory” to pharmacological to pharmacological prophylaxis? Neurol Sci 29:S55–S58PubMedCrossRef D’Amico D, Leone M, Grazzi L, Bussone G (2008) When should “chronic migraine” patients be considered “refractory” to pharmacological to pharmacological prophylaxis? Neurol Sci 29:S55–S58PubMedCrossRef
Metadata
Title
Peripheral neuromodulation in chronic migraine
Authors
F. Perini
A. De Boni
Publication date
01-05-2012
Publisher
Springer Milan
Published in
Neurological Sciences / Issue Special Issue 1/2012
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI
https://doi.org/10.1007/s10072-012-1039-4

Other articles of this Special Issue 1/2012

Neurological Sciences 1/2012 Go to the issue

ANIRCEF SYMPOSIUM: MIGRAINE AND DEPRESSION

Migraine and depression: bidirectional co-morbidities?

Posters

Posters

Oral Communications

Triptans: over the migraine